It's been a mediocre week for Omnicell, Inc. (NASDAQ:OMCL) shareholders, with the stock dropping 11% to US$40.16 in the week since its latest annual results. Revenues were US$1.1b, approximately ...

Importantly, our data indicates that Omnicell's profit was reduced by US$9.9m, due to unusual items, over the last year. It's never great to see unusual items costing the company profits ...

Omnicell's Q4 2024 earnings showed strong service revenue growth, despite soft overall revenue guidance, highlighting the service business as the key value driver. My updated DCF analysis yields a ...

CEO Randall Lipps highlighted that Omnicell exceeded bookings guidance for 2024, driven by strong connected devices demand. He emphasized the traction of the XT Amplify program and new customer ...

For the current quarter ending in March, Omnicell expects its per-share earnings to range from 15 cents to 25 cents. The company said it expects revenue in the range of $255 million to $265 ...

In the latest quarter, 4 analysts provided ratings for Omnicell OMCL, showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below illustrates the ...

Omnicell OMCL is advancing toward the industry-defined vision of Autonomous Pharmacy by leveraging automation and advanced services across its cloud-based platform. The strength of the company’s ...